Cointime

Regenerative Bio

company

About

Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing.

  • Cambridge,Massachusetts,United States
  • 11 - 50

Highlights

Total Funding Amount
$10M
Funding Rounds
1
Investors
6

Details

Last Funding Type
Angel
Last Funding Money Raised
$10M
Industries
Artificial Intelligence,Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2020
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Regenerative Bio Inc.

Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing, Regenerative Bio combines AI pharmaceutical-related technologies with biology to explore ingredients, formulations and therapies with anti-aging effects, and solve the problems caused by aging.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10M
Regenerative Bio has raised a total of $10M in funding over 2 rounds. Their latest funding was raised on Feb 25, 2022 from a Angel round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 25, 2022 Angel $10M 6 5Y Capital
IMO Ventures 		— Detail

Investors

Number of Lead Investors
Number of Investors
2
6
Regenerative Bio is funded by 6 investors. 5Y Capital and IMO Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
5Y Capital Yes Angel
IMO Ventures Yes Angel
K2VC — Angel
Taihill Venture — Angel
UpHonest Capital — Angel
Yael Capital Management Limited — Angel
Cointime
İçerikler
Şirket.